marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Eledon Pharmaceuticals Balance Sheet 2011-2024 | ELDN
Annual Balance Sheet Eledon Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-55.7 M | -84.1 M | -114 M | -8.47 M | -13 M | -17.2 M | -23.2 M | -24 M | -105 M | -31.8 M | -11.7 M | - | |
Long Term Debt |
- | 383 K | 400 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
383 K | 363 K | 369 K | 144 K | 180 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 144 K | - | - | 84 K | 88 K | - | 85.3 M | 49.8 M | - |
Total Current Liabilities |
3.9 M | 6.48 M | 4.4 M | 2.48 M | 1.32 M | - | - | 2.82 M | 6.16 M | 4.24 M | - | - | - |
Total Liabilities |
81.9 M | 8.61 M | 6.55 M | 6.59 M | 1.47 M | 2.53 M | 1.44 M | 2.9 M | 6.25 M | 4.24 M | 87.6 M | 51.9 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-319 M | -203 M | -115 M | - | -57.6 M | -41.6 M | -27.5 M | -169 M | -131 M | -86.4 M | -63.1 M | -47.3 M | - |
Total Assets |
89.1 M | 92.8 M | 171 M | 197 M | 10.9 M | 17 M | 20.9 M | 29.8 M | 68 M | 108 M | 32.3 M | 12 M | - |
Cash and Cash Equivalents |
4.61 M | 56.4 M | 84.8 M | 114 M | 8.79 M | 13 M | 17.2 M | 23.2 M | 24 M | 105 M | 31.8 M | 11.7 M | - |
Book Value |
7.21 M | 84.2 M | 164 M | 191 M | 9.46 M | 14.5 M | 19.5 M | 26.9 M | 61.7 M | 104 M | -55.3 M | -39.9 M | - |
Total Shareholders Equity |
7.21 M | 84.2 M | 164 M | 191 M | 9.46 M | 14.5 M | 19.5 M | -2.7 M | 61.7 M | 104 M | -55.3 M | -39.9 M | - |
All numbers in USD currency
Quarterly Balance Sheet Eledon Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
315 K | 386 K | - | - | 83 K | 184 K | 284 K | 383 K | 461 K | 299 K | 350 K | 400 K | 45 K | 90 K | - | - | - | 48 K | 97 K | 144 K | 144 K | 144 K | 144 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 94 K | 245 K | 48 K | 84 K | 120 K | 156 K | - | 88 K | 88 K | 88 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
38.5 M | 129 M | 6 M | 81.9 M | 60.5 M | 63 M | 7.51 M | 8.61 M | 8.49 M | 5.33 M | 5.06 M | 6.55 M | 6.42 M | 5.78 M | 7.81 M | 6.59 M | 6.59 M | 6.59 M | 6.59 M | 1.47 M | 1.47 M | 1.47 M | 1.47 M | 2.53 M | 2.53 M | 2.53 M | 2.53 M | 1.44 M | 1.44 M | 1.44 M | 1.44 M | 3.9 M | 3.9 M | 3.9 M | 2.9 M | 6.25 M | 6.25 M | 6.25 M | 6.25 M | 4.24 M | 4.24 M | 4.24 M | 4.24 M | 2.21 M | 2.21 M | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-311 M | -388 M | -253 M | -319 M | -289 M | -279 M | -214 M | -203 M | -144 M | -134 M | -125 M | -115 M | -106 M | -96.3 M | -88.9 M | -80.4 M | -80.4 M | -80.4 M | -80.4 M | -57.6 M | -57.6 M | -57.6 M | -57.6 M | -41.6 M | -41.6 M | -41.6 M | -41.6 M | -27.5 M | -27.5 M | -27.5 M | -27.5 M | -14.4 M | -14.4 M | -14.4 M | -169 M | -131 M | -131 M | -131 M | -131 M | -86.4 M | -86.4 M | -86.4 M | -86.4 M | -63.1 M | -63.1 M | - | - | - | - | - | - | - | - | - | - |
Total Assets |
115 M | 120 M | 80.8 M | 89.1 M | 96.1 M | 107 M | 82.3 M | 92.8 M | 150 M | 155 M | 161 M | 171 M | 177 M | 184 M | 192 M | 197 M | 197 M | 197 M | 197 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 17 M | 17 M | 17 M | 17 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 1.2 M | 1.2 M | 1.2 M | 29.8 M | 68 M | 68 M | 68 M | 68 M | 108 M | 108 M | 108 M | 108 M | 32.3 M | 32.3 M | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
6.75 M | 26 M | 5.66 M | 4.61 M | 3.67 M | 40.9 M | 46.5 M | 56.4 M | 65.9 M | 70.5 M | 76.7 M | 84.8 M | 94 M | 101 M | 109 M | 114 M | 114 M | 114 M | 114 M | 8.79 M | 8.79 M | 13.7 M | 8.79 M | 13 M | 16.3 M | 13 M | 13 M | 17.2 M | 19.1 M | 22.5 M | 24.4 M | 1.1 M | 1.1 M | 1.1 M | 23.2 M | 24 M | 24 M | 24 M | 24 M | 105 M | 105 M | 105 M | 105 M | 31.8 M | 31.8 M | - | - | 11.7 M | - | - | - | 2.25 M | - | - | - |
Book Value |
76.1 M | -8.5 M | 74.8 M | 7.21 M | 35.6 M | 43.8 M | 74.8 M | 84.2 M | 141 M | 149 M | 156 M | 164 M | 171 M | 179 M | 184 M | 191 M | 191 M | 191 M | 191 M | 9.46 M | 9.46 M | 9.46 M | 9.46 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M | -2.7 M | -2.7 M | -2.7 M | 26.9 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 104 M | 104 M | 104 M | 104 M | 30.1 M | 30.1 M | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
76.1 M | -8.5 M | 74.8 M | 7.21 M | 35.6 M | 43.8 M | 74.8 M | 84.2 M | 141 M | 149 M | 156 M | 164 M | 171 M | 179 M | 184 M | 191 M | 191 M | 191 M | 191 M | 9.46 M | 9.46 M | 9.46 M | 9.46 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M | -2.7 M | -2.7 M | -2.7 M | 26.9 M | 2.78 M | 61.7 M | 61.7 M | 61.7 M | 104 M | 104 M | 104 M | 104 M | -55.3 M | -55.3 M | - | - | -39.9 M | - | - | - | -30.4 M | - | - | - |
All numbers in USD currency